medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2026, Number 1

<< Back

Cir Plast 2026; 36 (1)

Justification of APPERT scale to stratify thrombosis risk in aesthetic surgery patients

Cuenca-Pardo J, Ramos-Gallardo G, Fernández-Díaz OF

Language: Spanish
References: 73
Page: 86-94
PDF size: 491.30 Kb.


ABSTRACT

Several ranges exist to stratify thrombosis risk; however, none are specifically designed for aesthetic surgery patients; therefore, basing prophylaxis on the risk levels indicated by these models is often ineffective and, in many cases, counterproductive. The objective of this work is to justify a scale called APPERT, which has already been validated and published. It is composed of thrombogenic factors that occur in aesthetic surgery procedures. This scale is highly sensitive and specific; it is very useful for stratifying thrombosis risk in patients undergoing aesthetic surgery and for decision-making regarding antithrombotic prophylactic care. To simplify its use, we created a free electronic scoring system, accessible in two versions: a web-based version and a mobile application. Information obtained from each user is stored in a database and used to revalidate the scale and make it more effective and straight forward. Prophylactic recommendations according to risk level were added to the electronic score, based on principles issued by the ACCP (American College of Chest Physicians) and ASH (American Society of Hematology); which is why the prophylactic recommendations are solid. We conclude that the APPERT scale is useful for stratifying thrombosis risk in aesthetic surgery patients and for justifying antithrombotic prophylaxis.


REFERENCES

  1. Cabrera-Rayo A, Nellen-Hummel H. Epidemiología de la enfermedad tromboembólica venosa. Gac Med Mex 2007; 143 (S1): 3-5.

  2. Zaragoza-Delgadillo JC, Sauri-Arce JCA, Ochoa-Carrillo FJ, Fuentes-del-Toro F. Prevención de la enfermedad tromboembólica venosa en cirugía. Gac Med Mex 2007; 143 (S1): 35-39.

  3. Sánchez HA. Profilaxis de la enfermedad tromboembólica venosa Cuad Cir 2000; 14: 44-54.

  4. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med 1999; 159: 445-453.

  5. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (Suppl 1): I22-I30.

  6. Kahn SR, Shbaklo H, Lamping DL et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105-1112.

  7. Prandoni P, Lensing AW, Cogo A et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.

  8. Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e185S-e194S. doi: 10.1378/chest.11-2289.

  9. Bovill EG, van der Vliet A. Venous valvular stasis-associated hypoxia and thrombosis: what is the link? Annu Rev Physiol 2011; 73: 527-545.

  10. Swanson E. Distal deep vein thrombosis causing pulmonary embolism after outpatient plastic surgery: a case report. Plast Reconstr Surg Glob Open 2020; 8: e2803.

  11. Hansrani V, Khanbhai M, McCollum C. The prevention of venous thromboembolism in surgical patients. Adv Exp Med Biol 2017; 906: 1-8. doi: 10.1007/5584_2016_100.

  12. Erem HH, Aytac E. The use of surgical care improvement projects in prevention of venous thromboembolism. Adv Exp Med Biol 2017; 906: 15-22. doi: 10.1007/5584_2016_102.

  13. Zanetto A, Senzolo M, Blasi A. Perioperative management of antithrombotic treatment. Best Pract Res Clin Anaesthesiol 2020; 34 (1): 35-50. doi: 10.1016/j.bpa.2020.01.003.

  14. White AJ, Kanapathy M, Nikkhah D, Akhavani M. Systematic review of the venous thromboembolism risk assessment models used in aesthetic plastic surgery. JPRAS Open 2021; 30: 116-127. doi: 10.1016/j.jpra.2021.07.010.

  15. Foppiani JA, Hernandez Alvarez A, Escobar-Domingo MJ, Thomas C, Lee D, Taritsa IC et al. Assessment of mortality rates associated with perioperative deep vein thrombosis screening and prophylaxis in cosmetic outpatient procedures: an updated national evaluation using QUAD a patient safety data. Aesthet Surg J Open Forum 2025; 7: ojaf105. doi: 10.1093/asjof/ojaf105.

  16. Vidal P, Berner JE, Will PA. Managing complications in abdominoplasty: a literature review. Arch Plast Surg 2017; 44 (5): 457-468. doi: 10.5999/aps.2017.44.5.457.

  17. Saad AN, Parina R, Chang D, Gosman AA. Risk of adverse outcomes when plastic surgery procedures are combined. Plast Reconstr Surg 2014; 134 (6): 1415-1422.

  18. Rao RB, Ely SF, Hoffman RS. Deaths related to liposuction. N England J Med 1999; 340 (19): 1471-1475.

  19. Grazer FM, Jong RH. Fatal outcomes from liposuction. Census survey of cosmetic surgeons. Plast Reconstr Surg 2000;105: 436-446.

  20. Agrawal NA, Hillier K, Kumar R, Izaddoost SA, Rohrich RJ. A review of venous thromboembolism risk assessment and prophylaxis in plastic surgery. Plast Reconstr Surg 2022; 149 (1): 121e-129e. doi: 10.1097/PRS.0000000000008663.

  21. Kraft CT, Janis JE. Deep venous thrombosis prophylaxis. Clin Plast Surg 2020; 47 (3): 409-414. doi: 10.1016/j.cps.2020.03.002.

  22. Katz BE, Bruck MC, Felsenfeld L et al. Power liposuction: report on complications. Dermatol Surg 2003; 29: 925-927.

  23. Hanke CW, Bullock S, Bernstein G. Current status of tumescent liposuction in the United States: national survey results. Dermatol Surg 1996; 22: 595-598.

  24. Hoefflin SM, Bornstein JB, Gordon M. General anesthesia in an office-based plastic surgical facility: a report on more than 23000 consecutive office-based procedures under general anesthesia with no significant anesthetic complications. Plats Reconst Surg 2001; 107: 243-251.

  25. Scarborough DA, Herron JB, Khan A, Bisaccia E. Experience with more than 5,000 cases in which monitored anesthesia care was used for liposuction surgery. Aesthetic Plast Surg 2003; 27: 474-480.

  26. Hanke CW, Bernstein G, Bullock S. Safety of tumescent liposuction in 15,336 patients. National survey results. Dermatol Surg 1995; 21: 459-462.

  27. Johnson PJ. General anesthesia in an office-based plastic surgical facility: a report on more than 23,000 consecutive office-based procedures under general anesthesia with no significant anesthetic complications. Arch Facial Plast Surg 2001; 3: 287.

  28. Ibarra P, Arango J, Bayter J, Castro J, Cortes J et al. Consenso de la Sociedad Colombiana de Anestesiología y Reanimación, SCARE y de la Sociedad Colombiana de Cirugía Plástica, sobre las recomendaciones para el manejo de pacientes electivos de bajo riesgo. Rev Col Anest 2010; 37 (4): 390-403.

  29. Winocour J, Gupta V, Ramírez JR, Shack RB, Grotting JC, Higdon KK. Abdominoplasty: Risk factor, Complications Rates, and Safety of combined procedures. Plast Reconst Surg 2015; 136: 597e-606e.

  30. Poore SO, Sillah N, Mahajan AY, Gotowski KA, Patient Safety in the operating room: II intraoperative and postoperative. Plast Reconst Surg 2012; 130: 1048-1058.

  31. Cárdenas Salomón CM, Gutiérrez-Salgado JE, Márquez-Espriella C, Sánchez-Medal FP, Gllardo-Palacios GJ, Eljure-Eljure M. Tromboprofilaxis en cirugía plástica: ¿cuándo, cómo y por qué? Cir Plast 2013;23 (3): 168-178.

  32. Lenhart M, Homann HH, Daigeler A et al. Major and lethal complication of liposuction. Plast Reconstr Surg 2008; 121: 396e-403e.

  33. Pannucci CJ. Evidence-based recipes for venous thromboembolism prophylaxis: a practical safety guide. Plast Reconst Surg 2017; 139: 520e-532e.

  34. Sweetland S, Green J, Liu B et al; Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009; 339: b4583.

  35. Aimé VL, Neville MR, Thornburg DA, Noland SS, Mahabir RC, Bernard RW. Venous thromboembolism prophylaxis in aesthetic surgery: a survey of plastic surgeons' practices. Aesthet Surg J 2020; 40 (12): 1351-1369. doi: 10.1093/asj/sjaa085.

  36. Cronin M, Dengler N, Krauss ES, Segal A, Wei N, Daly M et al. Completion of the updated Caprini risk assessment model (2013 version). Clin Appl Thromb Hemost 2019; 25: 1076029619838052. doi: 10.1177/1076029619838052.

  37. Caprini JA, Arcelus JI, Reyna JJ. Effective Risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38: 12-19.

  38. Golemi I, Salazar Adum JP, Tafur A, Caprini J. Venous thromboembolism prophylaxis using the Caprini score. Dis Mon 2019; 65 (8): 249-298. doi: 10.1016/j.disamonth.2018.12.005.

  39. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010; 251 (2): 344-350. doi: 10.1097/SLA.0b013e3181b7fca6.

  40. Pannucci CJ, Swistun L, MacDonald JK, Kenke PK, Brooke BS. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients. Ann Surg 2017; 265 (6): 1094-1103. doi: 10.1097/SLA.0000000000002126.

  41. Pannucci CJ. Evidence-based Recipes for venous thromboembolism prophylaxis: a practical safety guide. Plast Reconst Surg 2017; 139: 520e-532e.

  42. Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg 2011; 212 (1): 105-112.

  43. Pannucci CJ, Dreszer G, Wachtman CF, Bailey SH, Portschy PR, Hamill JB et al. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg 2011; 128 (5): 1093-1103. doi: 10.1097/PRS.0b013e31822b6817.

  44. Pannucci CJ, Fleming KI, Momeni A, Prazak AM, Agarwal J, Rockwell WB. Twice-daily enoxaparin among plastic surgery inpatients: an examination of pharmacodynamics, 90-day venous thromboembolism, and 90-day bleeding. Plast Reconstr Surg 2018; 141 (6): 1580-1590. doi: 10.1097/PRS.0000000000004379.

  45. Murphy RX, Schmitz D, Rosolowski K. Evidence-based practices for thromboembolism prevention: a report from the ASPS venous thromboembolism task force approved by ASPS Executive Committee: 2011. Available in: www.plasticsurgery.org/vte

  46. Campbell W, Pierson J, Cohen-Shohet R, Mast BA. Maximizing chemoprophylaxis against venous thromboembolism in abdominoplasty patients with the use of preoperative heparin administration. Ann Plast Surg 2014; 72 (6): S94-S96. doi: 10.1097/SAP.0000000000000132.

  47. Mittal P, Heuft T, Richter DF, Wiedner M. Venous thromboembolism (VTE) prophylaxis after abdominoplasty and liposuction: a review of the literature. Aesthetic Plast Surg 2020; 44 (2): 473-482. doi: 10.1007/s00266-019-01576-2.

  48. Keyes GR, Singer R, Iverson RE, Nahai F. Incidence and predictors of venous thromboembolism in abdominoplasty. Aesthet Surg J 2018; 38 (2): 162-173. doi: 10.1093/asj/sjx154.

  49. Swanson E. A new approach for venous thromboembolism prevention in plastic surgery. Plast Reconstr Surg Glob Open 2022; 10 (3): e4190. doi: 10.1097/GOX.0000000000004190.

  50. Swanson E. The case against chemoprophylaxis for venous thromboembolism prevention and the rationale for SAFE anesthesia. Plast Reconstr Surg Glob Open 2014; 2 (6): e160. doi: 10.1097/GOX.0000000000000116.

  51. Swanson E. Reconsidering the value of Caprini scores and venous thromboembolism (VTE) risk mitigation methods in plastic surgery patients. Aesthetic Plast Surg 2023; 47 (Suppl 1): 223-227. doi: 10.1007/s00266-023-03261-x.

  52. Swanson E. Abandoning Caprini scores and chemoprophylaxis ("Bloodletting 2.0"): a call for action. Ann Plast Surg 2023; 91 (1): 2-7. doi: 10.1097/SAP.0000000000003565.

  53. Swanson E. Are Caprini scores and chemoprophylaxis necessary to reduce the risk of venous thromboembolism after abdominoplasty? Plast Reconstr Surg Glob Open 2023; 11 (4): e4932. doi: 10.1097/GOX.0000000000004932.

  54. Swanson E. Enoxaparin dosing and the prevention of venous thromboembolism in plastic surgery patients. Plast Reconstr Surg 2017; 140 (6): 835e-836e. doi: 10.1097/PRS.0000000000003882.

  55. Swanson E. Clinical evaluation of 310 abdominoplasties and measurement of scar level. Ann Plast Surg 2023; 91 (1): 14-27. doi: 10.1097/SAP.0000000000003550.

  56. Swanson E. Prospective clinical study of 551 cases of liposuction and abdominoplasty performed individually and in combination. Plast Reconstr Surg Glob Open 2013; 1 (5): e32. doi: 10.1097/GOX.0b013e3182a333d7.

  57. Reinisch JF, Bresnick SD, Walker JW, Rosso RF. Deep venous thrombosis and pulmonary embolus after face lift: a study of incidence and prophylaxis. Plast Reconstr Surg 2001; 107 (6): 1570-1575; discussion 1576-1577. doi: 10.1097/00006534-200105000-00044.

  58. Swanson E. The expanding role of diagnostic ultrasound in plastic surgery. Plast Reconstr Surg Glob Open 2018; 6 (9): e1911. doi: 10.1097/GOX.0000000000001911.

  59. Swanson E. Prospective study of doppler ultrasound surveillance for deep venous thromboses in 1000 plastic surgery outpatients. Plast Reconstr Surg 2020; 145 (1): 85-96. doi: 10.1097/PRS.0000000000006343.

  60. Swanson E. Ultrasound surveillance offers a safe and effective method for venous thromboembolism prevention in plastic surgery patients. Aesthetic Plast Surg 2020; 44 (6): 2335-2339. doi: 10.1007/s00266-020-01935-4.

  61. Swanson E. Ethical concerns regarding high-dose enoxaparin for venous thromboembolism prevention in plastic surgery patients. Plast Reconstr Surg Glob Open 2019; 7 (8): e2485. doi: 10.1097/GOX.0000000000002485.

  62. Swanson E. Reconsidering the role of routine anticoagulation for venous thromboembolism prevention in plastic surgery. Ann Plast Surg 2020; 85 (2): 97-99. doi: 10.1097/SAP.0000000000002162.

  63. Swanson E. Caprini scores, risk stratification, and rivaroxaban in plastic surgery: time to reconsider our strategy. Plast Reconstr Surg Glob Open 2016; 4 (6): e733. doi: 10.1097/GOX.0000000000000660.

  64. Cuenca-Pardo J, Ramos-Gallardo G, Cárdenas-Camarena L, Contreras-Bulnes L, Lelevier De Alvear G. Searching for the best way to assess the risk of thrombosis in aesthetic plastic surgery; the role of the Caprini/Pannucci score. Aesthetic Plast Surg 2019; 43 (5): 1387-1395. doi: 10.1007/s00266-019-01428-z.

  65. Cuenca-Pardo J, Ramos-Gallardo G, Morales-Olivera M, Contreras-Bulnes L, Bucio-Duarte J, Iribarren-Moreno R et al. How to stratify the risk of thrombosis for esthetic plastic surgery? The proposal of a new scale. J Plast Reconstr Aesthet Surg 2023; 83: 361-372. doi: 10.1016/j.bjps.2023.03.005.

  66. Morales-Olivera M, Cuenca-Pardo J, Ramos-Gallardo G et al. Consenso de jueces y expertos para validar una escala que estratifique el riesgo de trombosis en pacientes a los que se les realizan procedimientos de cirugía estética. Cir Plast 2023; 33 (1): 4-13. doi: 10.35366/110919.

  67. American College of Chest Physicians Antithrombotic Guidelines. 9th ed. 2013. Available in: http://www.chestnet.org/Guidelines-and-Resources/Guidelines-and-Consensus-Statements/Antithrombotic-Guidelines-9th-Ed

  68. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): 7S-47S. doi: 10.1378/chest.1412S3. Erratum in: Chest. 2012; 141 (4): 1129. Dosage error in article text. Erratum in: Chest. 2012; 142 (6): 1698.

  69. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): e227S-e277S. doi: 10.1378/chest.11-2297. Erratum in: Chest. 2012; 141 (5): 1369.

  70. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): e278S-e325S. doi: 10.1378/chest.11-2404.

  71. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): e326S-e350S. doi: 10.1378/chest.11-2298. Erratum in: Chest. 2012; 141 (4): 1129.

  72. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): e152S-e184S. doi: 10.1378/chest.11-2295.

  73. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 381S-453S.




2020     |     www.medigraphic.com